The estimated Net Worth of Elliot Sigal is at least 27.1 百万$ dollars as of 12 October 2017. Elliot Sigal owns over 29 units of Bristol-Myers Squibb Co stock worth over 546,297$ and over the last 16 years Elliot sold BMY stock worth over 26,536,658$.
Elliot has made over 20 trades of the Bristol-Myers Squibb Co stock since 2009, according to the Form 4 filled with the SEC. Most recently Elliot bought 29 units of BMY stock worth 2,632$ on 12 October 2017.
The largest trade Elliot's ever made was selling 506,507 units of Bristol-Myers Squibb Co stock on 29 April 2013 worth over 20,113,393$. On average, Elliot trades about 63,768 units every 86 days since 2008. As of 12 October 2017 Elliot still owns at least 11,243 units of Bristol-Myers Squibb Co stock.
You can see the complete history of Elliot Sigal stock trades at the bottom of the page.
Over the last 16 years, insiders at Bristol-Myers Squibb Co have traded over 318,151,721$ worth of Bristol-Myers Squibb Co stock and bought 211,503 units worth 6,601,565$ . The most active insiders traders include Lamberto Andreotti、James M Cornelius、Giovanni Caforio. On average, Bristol-Myers Squibb Co executives and independent directors trade stock every 8 days with the average trade being worth of 1,682,720$. The most recent stock trade was executed by Cari Gallman on 1 August 2024, trading 1,061 units of BMY stock currently worth 51,554$.
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol-Myers Squibb Co executives and other stock owners filed with the SEC include: